Annual Total Long Term Liabilities
$56.50 M
+$53.67 M+1893.68%
31 December 2023
Summary:
Assembly Biosciences annual total long term liabilities is currently $56.50 million, with the most recent change of +$53.67 million (+1893.68%) on 31 December 2023. During the last 3 years, it has risen by +$38.26 million (+209.71%). ASMB annual total long term liabilities is now at all-time high.ASMB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$32.62 M
-$6.74 M-17.13%
30 September 2024
Summary:
Assembly Biosciences quarterly total long term liabilities is currently $32.62 million, with the most recent change of -$6.74 million (-17.13%) on 30 September 2024. Over the past year, it has increased by +$29.84 million (+1072.26%). ASMB quarterly long term liabilities is now -42.26% below its all-time high of $56.50 million, reached on 31 December 2023.ASMB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASMB Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1893.7% | +1072.3% |
| 3 y3 years | +209.7% | +247.1% |
| 5 y5 years | +45.2% | -28.1% |
ASMB Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1893.7% | -42.3% | +1072.3% |
| 5 y | 5 years | at high | +1893.7% | -42.3% | +1072.3% |
| alltime | all time | at high | -42.3% |
Assembly Biosciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $32.62 M(-17.1%) |
| June 2024 | - | $39.37 M(-18.9%) |
| Mar 2024 | - | $48.53 M(-14.1%) |
| Dec 2023 | $56.50 M(+1893.7%) | $56.50 M(+1930.2%) |
| Sept 2023 | - | $2.78 M(-0.5%) |
| June 2023 | - | $2.80 M(-0.6%) |
| Mar 2023 | - | $2.81 M(-0.7%) |
| Dec 2022 | $2.83 M(-53.2%) | $2.83 M(-22.4%) |
| Sept 2022 | - | $3.65 M(-19.0%) |
| June 2022 | - | $4.51 M(-13.8%) |
| Mar 2022 | - | $5.23 M(-13.7%) |
| Dec 2021 | $6.06 M(-66.8%) | $6.06 M(-35.6%) |
| Sept 2021 | - | $9.40 M(-42.8%) |
| June 2021 | - | $16.43 M(-4.3%) |
| Mar 2021 | - | $17.16 M(-5.9%) |
| Dec 2020 | $18.24 M(-56.8%) | $18.24 M(-3.7%) |
| Sept 2020 | - | $18.95 M(+82.0%) |
| June 2020 | - | $10.41 M(-74.2%) |
| Mar 2020 | - | $40.40 M(-4.4%) |
| Dec 2019 | $42.25 M(+8.6%) | $42.25 M(-6.9%) |
| Sept 2019 | - | $45.36 M(-3.2%) |
| June 2019 | - | $46.87 M(+7.4%) |
| Mar 2019 | - | $43.64 M(+12.1%) |
| Dec 2018 | $38.92 M(-8.8%) | $38.92 M(-0.0%) |
| Sept 2018 | - | $38.93 M(-3.1%) |
| June 2018 | - | $40.19 M(-3.1%) |
| Mar 2018 | - | $41.46 M(-2.9%) |
| Dec 2017 | $42.69 M | $42.69 M(-19.4%) |
| Sept 2017 | - | $52.96 M(-2.4%) |
| June 2017 | - | $54.25 M(-2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $55.44 M(+398.6%) |
| Dec 2016 | $11.12 M(-4.1%) | $11.12 M(-4.1%) |
| Sept 2016 | - | $11.60 M(0.0%) |
| June 2016 | - | $11.60 M(0.0%) |
| Mar 2016 | - | $11.60 M(0.0%) |
| Dec 2015 | $11.60 M(0.0%) | $11.60 M(0.0%) |
| Sept 2015 | - | $11.60 M(0.0%) |
| June 2015 | - | $11.60 M(0.0%) |
| Mar 2015 | - | $11.60 M(0.0%) |
| Dec 2014 | $11.60 M(>+9900.0%) | $11.60 M(-4.5%) |
| Sept 2014 | - | $12.14 M(>+9900.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(-100.0%) |
| June 2011 | - | $1.32 M(+1.9%) |
| Mar 2011 | - | $1.30 M(+1.9%) |
| Dec 2010 | $1.27 M(+8.5%) | $1.27 M(+2.0%) |
| Sept 2010 | - | $1.25 M(+1.8%) |
| June 2010 | - | $1.22 M(+2.4%) |
| Mar 2010 | - | $1.20 M(+2.0%) |
| Dec 2009 | $1.17 M(-79.1%) | $1.17 M |
| Dec 2008 | $5.62 M | - |
FAQ
- What is Assembly Biosciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Assembly Biosciences?
- What is Assembly Biosciences annual total long term liabilities year-on-year change?
- What is Assembly Biosciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Assembly Biosciences?
- What is Assembly Biosciences quarterly long term liabilities year-on-year change?
What is Assembly Biosciences annual total long term liabilities?
The current annual total long term liabilities of ASMB is $56.50 M
What is the all time high annual total long term liabilities for Assembly Biosciences?
Assembly Biosciences all-time high annual total long term liabilities is $56.50 M
What is Assembly Biosciences annual total long term liabilities year-on-year change?
Over the past year, ASMB annual total long term liabilities has changed by +$53.67 M (+1893.68%)
What is Assembly Biosciences quarterly total long term liabilities?
The current quarterly long term liabilities of ASMB is $32.62 M
What is the all time high quarterly long term liabilities for Assembly Biosciences?
Assembly Biosciences all-time high quarterly total long term liabilities is $56.50 M
What is Assembly Biosciences quarterly long term liabilities year-on-year change?
Over the past year, ASMB quarterly total long term liabilities has changed by +$29.84 M (+1072.26%)